The TLR4 Agonist Fibronectin Extra Domain A is Cryptic, Exposed by Elastase-2; use in a fibrin matrix cancer vaccine
出版年份 2015 全文链接
标题
The TLR4 Agonist Fibronectin Extra Domain A is Cryptic, Exposed by Elastase-2; use in a fibrin matrix cancer vaccine
作者
关键词
-
出版物
Scientific Reports
Volume 5, Issue 1, Pages -
出版商
Springer Nature
发表日期
2015-02-24
DOI
10.1038/srep08569
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- FibronectinEDA Promotes Chronic Cutaneous Fibrosis Through Toll-Like Receptor Signaling
- (2014) S. Bhattacharyya et al. Science Translational Medicine
- Enhancing Efficacy of Anticancer Vaccines by Targeted Delivery to Tumor-Draining Lymph Nodes
- (2014) L. Jeanbart et al. Cancer Immunology Research
- A Fusion Protein between Streptavidin and the Endogenous TLR4 Ligand EDA Targets Biotinylated Antigens to Dendritic Cells and Induces T Cell ResponsesIn Vivo
- (2013) Laura Arribillaga et al. Biomed Research International
- Concepts in psoriasis: psoriasis and the extracellular matrix
- (2012) J. McFadden et al. BRITISH JOURNAL OF DERMATOLOGY
- The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells
- (2012) Dennis Lindau et al. IMMUNOLOGY
- PROSPER: An Integrated Feature-Based Tool for Predicting Protease Substrate Cleavage Sites
- (2012) Jiangning Song et al. PLoS One
- The extradomain A of fibronectin (EDA) combined with poly(I:C) enhances the immune response to HIV-1 p24 protein and the protection against recombinant Listeria monocytogenes-Gag infection in the mouse model
- (2012) Beatriz San Román et al. VACCINE
- Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responses
- (2012) Francesc Rudilla et al. VACCINE
- Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin
- (2011) Cristina Mansilla et al. INTERNATIONAL JOURNAL OF CANCER
- Engineering the Growth Factor Microenvironment with Fibronectin Domains to Promote Wound and Bone Tissue Healing
- (2011) M. M. Martino et al. Science Translational Medicine
- The 12th–14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain
- (2010) Mikaël M. Martino et al. FASEB JOURNAL
- Fibronectin Growth Factor-Binding Domains Are Required for Fibroblast Survival
- (2010) Fubao Lin et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Psoriasis and streptococci: postscript regarding extra domain A fibronectin
- (2009) J. P. McFadden et al. BRITISH JOURNAL OF DERMATOLOGY
- Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 protein
- (2009) Cristina Mansilla et al. JOURNAL OF HEPATOLOGY
- In VivoStudies on the Effect of Co-Encapsulation of CpG DNA and Antigen in Acid-Degradable Microparticle Vaccines
- (2009) Tristan T. Beaudette et al. MOLECULAR PHARMACEUTICS
- In Situ Regulation of DC Subsets and T Cells Mediates Tumor Regression in Mice
- (2009) O. A. Ali et al. Science Translational Medicine
- Controlling integrin specificity and stem cell differentiation in 2D and 3D environments through regulation of fibronectin domain stability
- (2008) Mikaël M. Martino et al. BIOMATERIALS
- Myeloid-derived suppressor cell role in tumor-related inflammation
- (2008) Luigi Dolcetti et al. CANCER LETTERS
- A high-affinity human monoclonal antibody specific to the alternatively spliced EDA domain of fibronectin efficiently targets tumor neo-vasculaturein vivo
- (2008) Alessandra Villa et al. INTERNATIONAL JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started